Helene Severac-Chevrou

Boudry, NE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Use of Real-World Evidence in Health Technology Assessments of Non-Oncology Rare Disease Therapies.

Use of Real-World Evidence in Health Technology Assessments of Non-Oncology Rare Disease Therapies.

Journal: Journal of market access & health policy

Published: February 10, 2026

Real-World Study of Management and Outcomes of Patients with Lysosomal Acid Lipase Deficiency (LAL-D) in France.

Real-World Study of Management and Outcomes of Patients with Lysosomal Acid Lipase Deficiency (LAL-D) in France.

Journal: Advances in therapy

Published: October 06, 2025

Quality of Life in Wilson's Disease: A Systematic Literature Review.

Quality of Life in Wilson's Disease: A Systematic Literature Review.

Journal: Journal of health economics and outcomes research

Published: September 27, 2021

Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.

Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.

Journal: Applied health economics and health policy

Published: August 25, 2021

Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis.

Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis.

Journal: European journal of haematology

Published: December 20, 2019

Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.

Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.

Journal: Trials

Published: July 24, 2019

Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report.

Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: January 08, 2019

Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK.

Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: October 31, 2017

Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care.

Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care.

Journal: PharmacoEconomics

Published: October 21, 2017

International Regulations and Recommendations for Utility Data for Health Technology Assessment.

International Regulations and Recommendations for Utility Data for Health Technology Assessment.

Journal: PharmacoEconomics

Published: October 21, 2017

A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models.

A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models.

Journal: PharmacoEconomics

Published: October 21, 2017

Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review.

Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: October 06, 2017

Showing 1-12 of 21

Last Updated: 09/26/2026